Associations between body composition and radiotherapy-related side-effects and health-related quality of life in patients with prostate or lung cancer: sub-analysis of the REQUITE trial
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND Body composition is emerging as a prognostic biomarker in cancer and may be associated with treatment tolerance, side-effects, and health-related quality of life (HRQoL). It can be measured from imaging routinely acquired during patient care. We evaluated whether body composition metrics were associated with radiotherapy-related side-effects and HRQoL in patients with prostate or lung cancer using a prospective multicentre dataset. METHODS Radiotherapy planning computed tomography (CT) scans, patient and disease characteristics, and clinician- and patient-reported side-effects up to 24 months post-treatment were obtained from the REQUITE study. Skeletal muscle and intramuscular adipose tissue were segmented at the L3 and T12 vertebrae for prostate and lung patients respectively using in-house software. Standardised total average toxicity scores captured composite acute and late clinician- and patient-reported side-effects and HRQoL. Gradient boosted machine models were developed for all endpoints with and without body composition variables. Predictor importance rankings and model performance (root mean squared error (RMSE)) were assessed. RESULTS 279 lung and 848 prostate patients were available for analysis. Body composition variables were ranked in the top five most important variables for 9 of 12 endpoints. Body composition variables were ranked higher than body mass index for 9 of 12 endpoints. Adding body composition variables was associated with statistically significant (p < 0.01) but small reductions in apparent/in-sample RMSE across endpoints. CONCLUSIONS Body composition variables were frequently ranked among important predictors of radiotherapy-related side-effects and HRQoL, but their incremental improvement in apparent model fit was small. These findings suggest that CT-derived body composition may warrant further investigation as an exploratory imaging biomarker, but external validation and demonstration of clinically meaningful incremental value are required before clinical implementation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Gradient boosting machines, a tutorial
Natekin, A., & Knoll, A. (2013) · Frontiers in Neurorobotics · doi:10.3389/fnbot.2013.00021 · Cited by 3,887
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Cancer and Radiation Therapy: Current Advances and Future Directions
Baskar, R., Lee, K. A., Yeo, R., & Yeoh, K.-W. (2012) · International Journal of Medical Sciences · doi:10.7150/ijms.3635 · Cited by 2,880
Bradley, J. D., Paulus, R., Komaki, R., Masters, G., Blumenschein, G., Schild, S., Bogart, J., Hu, C., Forster, K., Magliocco, A., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71207-0 · Cited by 2,015
Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review
Shachar, S. S., Williams, G. R., Muss, H. B., & Nishijima, T. F. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2015.12.030 · Cited by 1,099
De Ruysscher, D., Niedermann, G., Burnet, N. G., Siva, S., Lee, A. W. M., & Hegi-Johnson, F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0064-5 · Cited by 868
Accounting for missing data in statistical analyses: multiple imputation is not always the answer
Hughes, R. A., Heron, J., Sterne, J. A. C., & Tilling, K. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyz032 · Cited by 802
Reisinger, K. W., van Vugt, J. L. A., Tegels, J. J. W., Snijders, C., Hulsewé, K. W. E., Hoofwijk, A. G. M., Stoot, J. H., Von Meyenfeldt, M. F., Beets, G. L., Derikx, J. P. M., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000000628 · Cited by 507
Radiation therapy‐associated toxicity: Etiology, management, and prevention
Wang, K., & Tepper, J. E. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21689 · Cited by 449
Baracos, V. E., & Arribas, L. (2018) · Annals of Oncology · doi:10.1093/annonc/mdx810 · Cited by 362
Myosteatosis and prognosis in cancer: Systematic review and meta-analysis
Aleixo, G. F. P., Shachar, S. S., Nyrop, K. A., Muss, H. B., Malpica, L., & Williams, G. R. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.102839 · Cited by 345
Shachar, S. S., Deal, A. M., Weinberg, M., Nyrop, K. A., Williams, G. R., Nishijima, T. F., Benbow, J. M., & Muss, H. B. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0940 · Cited by 288
Ahn, J. S., Ahn, Y. C., Kim, J.-H., Lee, C. G., Cho, E. K., Lee, K. C., Chen, M., Kim, D.-W., Kim, H.-K., Min, Y. J., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.0130 · Cited by 261
Trejo-Avila, M., Bozada-Gutiérrez, K., Valenzuela-Salazar, C., Herrera-Esquivel, J., & Moreno-Portillo, M. (2021) · International Journal of Colorectal Disease · doi:10.1007/s00384-021-03839-4 · Cited by 226
Li, J., Guo, S., Ma, R., He, J., Zhang, X., Rui, D., Ding, Y., Li, Y., Jian, L.-Y., Cheng, J., et al. (2024) · BMC Medical Research Methodology · doi:10.1186/s12874-024-02173-x · Cited by 212
Ringborg, U., Bergqvist, D., Brorsson, B., Cavallin-ståhl, E., Ceberg, J., Einhorn, N., Frödin, J.-E., Järhult, J., Lamnevik, G., Lindholm, C., et al. (2003) · Acta Oncologica · doi:10.1080/02841860310010826 · Cited by 208
Shachar, S. S., Deal, A. M., Weinberg, M., Williams, G. R., Nyrop, K. A., Popuri, K., Choi, S. K., & Muss, H. B. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2266 · Cited by 161
Machine Learning-Based Models for Prediction of Toxicity Outcomes in Radiotherapy
Isaksson, L. J., Pepa, M., Zaffaroni, M., Marvaso, G., Alterio, D., Volpe, S., Corrao, G., Augugliaro, M., Starzyńska, A., Leonardi, M. C., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00790 · Cited by 151
Chu, C., Belavý, D. L., Armbrecht, G., Bansmann, M. P., Felsenberg, D., & Zheng, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143327 · Cited by 145
Seibold, P., Webb, A. J., Aguado-Barrera, M. E., Azria, D., Bourgier, C., Brengues, M., Briers, E., Bultijnck, R., Calvo, P., Carballo, A. M., et al. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2019.04.034 · Cited by 109
Self-citationBarnett, G. C., West, C., Coles, C. E., Pharoah, P. D. P., Talbot, C. J., Elliott, R. M., Tanteles, G. A., Symonds, R. P., Wilkinson, J. S., Dunning, A. M., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.03.015 · Cited by 70
Self-citationMurimwa, G. Z., Venkat, P. S., Jin, W. H., Leuthold, S., Latifi, K., Almhanna, K., Pimiento, J. M., Fontaine, J. P., Hoffe, S. E., & Frakes, J. M. (2017) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2017.06.11 · Cited by 50
Intensity‐modulated radiation therapy
Lee, N. Y., & Terezakis, S. A. (2008) · Journal of Surgical Oncology · doi:10.1002/jso.21014 · Cited by 47
Tromp, D., & Christie, D. (2015) · Clinical Oncology · doi:10.1016/j.clon.2015.05.001 · Cited by 38
Massi, M. C., Gasperoni, F., Ieva, F., Paganoni, A. M., Zunino, P., Manzoni, A., Franco, N. R., Veldeman, L., Ost, P., Fonteyne, V., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.541281 · Cited by 38
Self-citationTan, D. C. L., Nasir, N. F. M., Manan, H. A., & Yahya, N. A. (2023) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2023.05.001 · Cited by 25
Matsuo, Y., Mitsuyoshi, T., Shintani, T., Iizuka, Y., & Mizowaki, T. (2018) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2018.05.003 · Cited by 23
Zhang, W., Tang, J. P., Tang, H., Xie, L., Wang, J., Wu, J., & Yang, M. J. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.10.006 · Cited by 23
Zwart, A. T., Pörtzgen, W., van Rijn–Dekker, M. I., Sidorenkov, G. A., Dierckx, R., Steenbakkers, R. J. H. M., Wegner, I., van der Hoorn, A., de Bock, G. H., & Halmos, G. B. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164650 · Cited by 20
Sorjonen, K., Ingre, M., Nilsonne, G., & Melin, B. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15746 · Cited by 18
McSweeney, D. M., HENDERSON, E., van Herk, M., Weaver, J. M. J., Bromiley, P. A., Green, A., & McWilliam, A. (2022) · Medical Physics · doi:10.1002/mp.15533 · Cited by 17
Self-citationAdvances in Image-Guided Adaptive Radiation Therapy
Bertholet, J., Vinogradskiy, Y. Y., Hu, Y., & Carlson, D. J. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2021.02.047 · Cited by 16
Prognostic Impact of Sarcopenia’s Occurrence during Radiotherapy in Oropharyngeal Cancer Patients
Bergamaschi, L., Marvaso, G., Zaffaroni, M., Vincini, M. G., D’Ecclesiis, O., Volpe, S., Ferrari, A., Zorzi, S. F., Rocca, M. C., Sabbatini, A., et al. (2023) · Cancers · doi:10.3390/cancers15030723 · Cited by 12
Medical Resource Use and Medical Costs for Radiotherapy-Related Adverse Effects: A Systematic Review
Chen, Y. H., Molenaar, D., Groot, C. A. U., van Vulpen, M., & Blommestein, H. M. (2022) · Cancers · doi:10.3390/cancers14102444 · Cited by 7
He, S., Zhang, G., Huang, N., Chen, S., Ruan, L., Liu, X., & Zeng, Y. (2024) · Asia-Pacific Journal of Oncology Nursing · doi:10.1016/j.apjon.2024.100512 · Cited by 7
Cited by
Still being checked.
Metadata
- Authors
- Vickers, A. J., McSweeney, D. M., Choudhury, A., Weaver, J., West, C., Kerns, S., Azria, D., Farcy-Jaquet, M.-P., Chang-Claude, J., Dunning, A., Lambrecht, M., Avuzzi, B., De Ruysscher, D., Seibold, P., Sperk, E., Talbot, C., Vega, A., Veldeman, L., Bultijnck, R., Webb, A., Rosenstein, B., Rancati, T., Gioscio, E., Price, G., & McWilliam, A.
- Affiliations
- University of Manchester (GB)
- Medical College of Wisconsin (US)
- Inserm (FR)
- Universität Hamburg (DE)
- University of Cambridge (GB)
- KU Leuven (BE)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- German Cancer Research Center (DE)
- Heidelberg University (DE)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Ghent University Hospital (BE)
- University of Leicester (GB)
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Vickers, Alexander J.
- ORCID
- Vickers, Alexander J.
- McSweeney, Donal M.
- Choudhury, Ananya
- Weaver, Jamie
- West, Catherine
- Kerns, Sarah
- Azria, David
- Chang-Claude, Jenny
- Dunning, Alison
- Lambrecht, Maarten
- Avuzzi, Barbara
- De Ruysscher, Dirk
- Seibold, Petra
- Sperk, Elena
- Talbot, Christopher
- Vega, Ana
- Veldeman, Liv
- Bultijnck, Renée
- Webb, Adam
- Rancati, Tiziana
- Gioscio, Eliana
- Price, Gareth
- McWilliam, Alan
- Venue
- Radiotherapy and Oncology
- Publisher
- Elsevier BV
- Published
- 2026-09
- Volume
- 222
- Pages
- 111673
- ISSN
- 0167-8140 (ISSN-L)
- OpenAlex
- W7166353596
- Semantic Scholar
- e697c7dce69ffb622a8ce1d379f0c80a76486cb6
- Cited by
- 0
- References
- 37
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Radiotherapy and Oncology (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion)
- Funders
- NIHR Manchester Biomedical Research Centre (NIHR203308)
- Cancer Research UK (RRCOER-Jun24/100008, CTRQQR-2021\\100010, C1994/A28701)
- NIHR Imperial Biomedical Research Centre
- Cancer Research UK Manchester Centre
- National Institute for Health and Care Research
- Topics
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
- Keywords
- body composition, radiotherapy complications, health-related quality of life, prostate cancer, lung cancer, skeletal muscle, intramuscular fat, CT-derived body composition, imaging biomarkers, prognostic factors, toxicity prediction
- MeSH terms
- Aged, Body Composition, Humans, Lung Neoplasms, Male, Middle Aged, Prospective Studies, Prostatic Neoplasms, Quality of Life, Tomography, X-Ray Computed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.